z-logo
open-access-imgOpen Access
Successful use of splenectomy in a patient with hepatitis C virus-related thrombocytopenia
Author(s) -
Xilian Huang,
Yaping Xie,
Daquan Gao,
Pengfei Shi,
Shenxian Qian
Publication year - 2015
Publication title -
the journal of infection in developing countries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 49
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.5084
Subject(s) - splenectomy , medicine , thrombopoietin , platelet , contraindication , refractory (planetary science) , hepatitis c virus , gastroenterology , immunology , serology , hepatitis c , surgery , antibody , virus , spleen , pathology , physics , alternative medicine , stem cell , haematopoiesis , biology , astrobiology , genetics
This case report describes a 44-year-old female with hepatitis C virus-related thrombocytopenia. The laboratory tests showed a platelet count of 3×10⁹/l, positive HCV serology and high serum concentration of HCV-RNA of 6.74×10⁶ copy/ml. She was refractory to standard therapies including corticosteroids, intravenous immunoglobulin (IVIG), thrombopoietin (TPO) and even interferon (IFN) regimens, due to the persistence of a low platelet count. At first, splenectomy was thought to be impossible, but then splenectomy was successfully performed and patient showed good tolerance and a constant normal platelet count after surgery. In conclusion, splenectomy is feasible in selected patients and may allow us to acquire a reasonable platelet count and completion of an anti-HCV protocol. Low platelet count itself should not be the contraindication of operation specifically for these patients. Further studies in larger numbers of patients and over a longer period of time are warranted.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom